Dr. Tobias Schmelzle, Novartis Institutes for Biomedical Research
Identifying and validating novel cancer targets
Start Date
05.12.2018 - 17:15
Event End
05.12.2018 - 18:00
Location
ETH Zürich, Hönggerberg
Identifying and validating novel cancer targets